| Financial Year |
March 31 2023 |
| Monetary Funds |
342,507,955.16 |
| Held-for-trading Financial Assets |
23,043,936.98 |
| Notes Receivable |
67,341,263.78 |
| Accounts Receivable |
89,292,618.82 |
| Advances to Suppliers |
4,726,258.25 |
| Other Receivables |
38,357,261.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
57,942,241.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
767,166.14 |
| Other Current Assets |
622,750.00 |
| Total Current Assets |
635,274,293.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
164,734,731.52 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,430,847.45 |
| R&D expenses |
-- |
| Goodwill |
106,129,868.09 |
| Long-Term Deferred and Prepaid Expenses |
37,532,900.56 |
| Deferred Income Tax Assets |
17,148,794.62 |
| Other Non-Current Assets |
3,397,752.78 |
| Sub-Total of Non-Current Assets |
438,411,154.78 |
| Total Assets |
1,073,685,448.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
68,705,610.04 |
| Accounts Received In Advance |
151,498.64 |
| Employee Compensation Payable |
8,076,129.22 |
| Taxes Payable |
16,062,917.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,523,861.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,597,787.49 |
| Other Current Liabilities |
48,885,404.40 |
| Sub-Total of Current Liabilities |
265,117,880.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,915.62 |
| Other Non-Current Liabilities |
1,072,544.70 |
| Sub-Total of Non-Current Liabilities |
31,793,220.05 |
| Total Liabilities |
296,911,100.69 |
| Paid-In Capital(Or Share Stock) |
329,143,329.00 |
| Capital Surplus |
400,145,323.23 |
| Surplus Reserve |
41,510,111.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,840,027.67 |
| Minority Stockholder's Interest |
1,372,298.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
775,402,049.52 |
| Owner's Equity（Stockholder's Equity） |
776,774,347.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,073,685,448.28 |
